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we built this CAD system and we validated its reliability,
we decided to test 10 patients with a biopsy confirmed PCa.
All of them underwent MRI performing a conventional
study with T1-w, T2-w and diffusion sequences. After
precontrast acquisitions, patients were intravenously given
gadobutrol and a total of 28 phases were acquired, each
lasting 13 seconds. All images were examined by an expert
radiologist on the basis of histological information provided
after surgery and a total of 13 tumours, all located in the
peripheral zone (PZ), were detected. A ROI was drawn
around each lesion, on all possible slices to cover the whole
tumour extension. When possible a ROI on a healthy region,
with dimension comparable to that of the corresponding
malignant ROI was also drawn for each patient. Information
of pixels belonging to the same ROI were extracted from
both T2-w sequence and the 28DCE volume acquisitions, to
construct time-intensity curves over time. A filtering
operation was performed to reduce noise contribution and
signal to noise ratio was estimated to discard low quality
data. T2-w images were used to evaluate mean grey value
of pixels on selected ROIs, while DCE-MRI points were
analyzed applying three different quantitative models (Tofts,
Weibull, EU1) and a semiquantitative description (peak
location and maximum enhancement, initial slope, curve
wash-out, area under the curve). A total of 13 features were
collected for each pixel. The initial features set was reduced
in order to avoid over-fitting problems and to discard
redundant information. Furthermore when a couple of
highly correlated features occurred, the parameter of the
couple with lower performances rate was discarded. On the
basis of these elaboration steps a 6-dimensional vector was
generated for all the pixels in which model fitting was
successful. Malignancy probabilities were then calculated
with the Bayes rule. Results: The resulting area under the
receiver operating characteristic (ROC) curve was 0.874;
sensitivity and specificity were 84.6% and 83.4%
respectively. Good separation between malignant and benign
points can be observed for the three combination of
parameters shown on the Scatter plots of the three
quantitative models implemented. Conclusion: The CAD
scheme presented in this study shows good performance in
discriminating between benign and malignant regions in the
prostate. This system achieves a high sensitivity and
specificity, leading to a better lesion detection rate. Future
developments will focus on integrating the dataset with
information from diffusion, in order to further improve
system performances.
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Introduction and Objectives: Simple enucleation (TE) showed
excellent oncological results in large retrospective series. No
study has compared oncologic outcomes after TE and radical
nephrectomy (RN) for the treatment of pT1 RCC. The aim of
the present study is to compare the oncologic outcomes after
TE and RN in pT1 RCCs. Patients and Methods: We
retrospectively analyzed 475 patients who underwent TE or
RN for pT1 RCC, N0, M0 between 1995 and 2007. TE was
done in 332 patients, while RN in 143. Local recurrence,
progression-free survival (PFS) and cancer-specific survival
(CSS) were the main outcomes of this study. The Kaplan-
Meier method was used to calculate survival functions, and
differences were assessed with log-rank statistics. Univariate
and multivariate Cox regression models were also used.
Results: The surgical margin status of tumors that had TE was
always negative. The mean follow-up was 72±44 mo after RN
and 58±38 mo after TE (p=0.0004). At last follow-up, 393
patients (82.7%) were alive and disease free and 56 (11.8%)
had died of other causes. Overall, 26 patients experienced
progressive disease (5.4%) and of those 5 were alive but with
disease progression (1%) and 21 (4.4%) had died of metastatic
disease. No local recurrences were observed in the patients
who underwent RN. Overall, 3 patients with pT1a RCC
developed isolated renal recurrence after TE and this was
always elsewhere in the kidney. Specifically, all patients
diagnosed having local recurrences had negative surgical
margins. The 5- and 10-yr PFS estimates were 91.3% and
88.7% after RN and 95.3 and 92.8% after TE (p=NS). The 5-
and 10-yr CSS estimates were 92.1% and 89.4% after RN and
94.4% (5- and 10-yr CSS) after TE (p=NS). No statistically
significant differences between RN and TE were found after
adjusting CSS probabilities according to age at surgery (≤65
yr, log-rank p-value: 0.99; or >65 yr, log-rank p-value: 0.14),
grade (Fuhrman nuclear grades 1-2, log-rank p-value: 0.48;
grade 3, log-rank p-value: 0.89; or grade 4, log-rank p-value:
0.62), stage (pT1a, log-rank p value: 0.46; or pT1b, log-rank
p-value: 0.44) or clear cell subtype (log-rank p-value: 0.37).
Surgical treatment failed to be a predictor of PFS or CSS both
at univariable and multivariable analyses. The potential
limitation of the present study includes that the data originate
from a retrospective review. Conclusion: TE can achieve
oncologic results similar to those of RN for the treatment of
pT1 RCCs provided tumors are carefully selected based on
their safe and complete removal.
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